Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Melnick

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Leukemia|February 18, 2021
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myelomaArantxa Carrasco-Leon, Teresa Ezponda, Cem Meydan, et al.
Nature Communications|June 3, 2014
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphomaMichael R Green, Carolina Vicente-Dueñas, Isabel Romero-Camarero, et al.
Cancer Discovery|February 13, 2018
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid LeukemiaFiona C Brown, Eric Still, Richard P Koche, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Nature Materials|March 17, 2023
Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomasShivem B Shah, Christopher R Carlson, Kristine Lai, et al.
Cell Reports|December 9, 2014
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaRaajit Rampal, Altuna Alkalin, Jozef Madzo, et al.
Nature Medicine|October 6, 2015
Loss of BAP1 function leads to EZH2-dependent transformationLindsay M LaFave, Wendy Béguelin, Richard Koche, et al.
Nature Medicine|June 9, 2016
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"Lindsay M LaFave, Wendy Béguelin, Richard Koche, et al.
Cancer Cell|August 14, 2019
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine MethylationJia Yi Fong, Luca Pignata, Pierre-Alexis Goy, et al.
Science (New York, N.Y.)|January 19, 2023
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformationCoraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Leukemia|February 18, 2021
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myelomaArantxa Carrasco-Leon, Teresa Ezponda, Cem Meydan, et al.
Nature Communications|June 3, 2014
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphomaMichael R Green, Carolina Vicente-Dueñas, Isabel Romero-Camarero, et al.
Cancer Discovery|February 13, 2018
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid LeukemiaFiona C Brown, Eric Still, Richard P Koche, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Nature Materials|March 17, 2023
Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomasShivem B Shah, Christopher R Carlson, Kristine Lai, et al.
Cell Reports|December 9, 2014
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemiaRaajit Rampal, Altuna Alkalin, Jozef Madzo, et al.
Nature Medicine|October 6, 2015
Loss of BAP1 function leads to EZH2-dependent transformationLindsay M LaFave, Wendy Béguelin, Richard Koche, et al.
Nature Medicine|June 9, 2016
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"Lindsay M LaFave, Wendy Béguelin, Richard Koche, et al.
Cancer Cell|August 14, 2019
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine MethylationJia Yi Fong, Luca Pignata, Pierre-Alexis Goy, et al.
Science (New York, N.Y.)|January 19, 2023
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformationCoraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Pageof 23